title: Combined hemodynamic support with the Impella 2.5 device and intra-aortic balloon pump for management of refractory cardiogenic shock.
abstract: Cardiogenic shock (CS) during elective percutaneous coronary intervention (PCI) is a rare but potentially lethal clinical condition. Pharmacological inotropic support and mechanical circulatory assistance with intra-aortic balloon pump (IABP) counterpulsation remains the gold-standard treatment. We report the case of a patient who developed refractory CS during elective PCI and was successfully managed with concomitant use of IABP and the Impella 2.5 L support device.
authors.affiliation: Department of Cardiology, St. Thomas' Hospital, Westminster Bridge Road, London, UK SE1 7EH. antonispav@yahoo.com.
authors.forename: Antonios N
authors.initials: AN
authors.lastname: Pavlidis
authors.forename: Simon R
authors.initials: SR
authors.lastname: Redwood
authors.forename: Brian R
authors.initials: BR
authors.lastname: Clapp
mesh_terms: D002316:Cardiotonic Agents; D003131:Combined Modality Therapy; D003324:Coronary Artery Disease / Q000628:therapy; D005260:Female; D006353:Heart-Assist Devices; D006439:Hemodynamics / Q000502:physiology*; D006440:Hemofiltration; D006801:Humans; D007423:Intra-Aortic Balloon Pumping; D008875:Middle Aged; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects; D012770:Shock, Cardiogenic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents